Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Concordia Healthcare Corp. T.CXR.R



TSX:CXR.R - Post by User

Post by Stockcoach1on Apr 08, 2015 12:37pm
221 Views
Post# 23609119

If we listened to your nonsense we'd be missing out on today

If we listened to your nonsense we'd be missing out on today
It's unbelievable that there is so much negativity toward a company that has performed beyond our wildest imagination. 
If you made money and wish to get out, then do it. It's your decision. But when you start making stupid uninformed comments that "the stock is dead in the water until the next catalyst and the longer we wait for it, the better chance it drifts down" you are talking nonsense.

Before you tweet your negative, stupid opinions check out the facts and history. CXR gained much more between the deals than it gained when the deals were announced. 
 
When Donnatal purchase was announced the stock gained a few buck.
When Zonegran purchase was announced the stock didn't gain anything.
When Covis purchase was announced the stock gained $16.00-$20.00
All drugs prior to these 3 we're priced into the IPO of $6.25
So when you break it down the purchase announcements (catalysts) combined account for about $26.00 -$30.00 of share value. 
 
Conversely, the waiting time in anticipation of the purchase deal (catalyst) resulted in $56.00-$60.00 dollars in shareholder value.
Waiting between the deals in anticipation of a (catalyst) is the biggest paycheque. Waiting in anticipation for another catalyst will drive the stock to $110.00 plus.
If you follow the principle of "buy on roomer and sell on news" then you should have sold at $90.00 and re-bought at $84.00 because we're at below value. This is where the anticipation starts. That's why RBC (smart money) did a $368 million "bought deal" at $85.00 and that's why Mark cleared the slate yesterday with the $610 million bond issue. Now he is poised to make the biggest deal yet.
 
My senses tell me CXR is on the cusp of another very big acquisition, as this latest one was only initiated unexpectedly in January. What do you think Mark has been doing for the last 3/4 of a year prior to the Covis deal? Certainly not sitting on his laurels. 
As Mark stated, the pipeline is full and he no longer solicits. They come to him.
 
The Jet - if there even is one - may be necessary to bring in deals that are time sensitive and require dozens of meetings. Mark is very prudent and focus driven. He does not appear to be egocentric. If there is in fact a Jet on which you tried to persuade shareholders to bail out, then provide the proof. Is the Jet purchased, leased or even existent? And don't make blanket statement that insinuates that a corporate Jet is the end of company.
 
If people listened to your nonsense, then they would be missing out on a today's current $4.00 gain. But I'm sure tomorrow you'll be tweeting how you made money today even though you said  "you were out" 2 days ago.
 
 
 
CXR climbing to 110.00 plus....What's not to like.
  1.  
<< Previous
Bullboard Posts
Next >>